Defective glycosylation of calsequestrin in heart failure

Cardiovascular Research
Arash KiarashSteven E Cala

Abstract

Levels of Ca2+ regulatory proteins have been extensively analyzed in cardiomyopathies as possible indices of change in sarcoplasmic reticulum (SR) structure and function. Measures of calsequestrin (CSQ), however, a critical protein component of the Ca2+ release complex in junctional sarcoplasmic reticulum, have provided little or no evidence of underlying dysfunction. We previously reported that calsequestrin isolated from heart tissue exists in a variety of glycoforms and phosphoforms reflecting mannose trimming of N-linked glycans and phosphorylation and dephosphorylation on protein kinase CK2-sensitive sites. Here, we tested whether the distribution of molecular forms changes in heart failure (HF) reflecting possible remodeling of diseased tissue. Canine hearts were paced (220 beats/min) for 6-8 weeks to induce heart failure. Calsequestrin was purified from heart failure and sham-operated (control) treated canine ventricles and analyzed by electrospray mass spectrometry. The results showed striking changes in the mass distribution of calsequestrin molecules present in tissue from heart failure (five animals) compared with control (five animals). In heart failure, calsequestrin contained glycan structures that were uncharacte...Continue Reading

Citations

Mar 25, 2011·Molecular and Cellular Biochemistry·Timothy P McFarlandSteven E Cala
Oct 24, 2012·Nature Reviews. Cardiology·Changwon KhoRoger J Hajjar
Nov 30, 2011·The Journal of Biological Chemistry·Keun Woo LeeKi-Sun Kwon
Dec 16, 2011·The Journal of Biological Chemistry·Emiliano J SanchezChulHee Kang
Mar 30, 2012·The Journal of Biological Chemistry·Ang GuoLong-Sheng Song
Dec 27, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Michela Faggioni, Björn C Knollmann
Sep 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Zuzana KubalovaSandor Györke
Feb 12, 2014·Pflügers Archiv : European journal of physiology·Aleksey V ZimaDmitry Terentyev
Dec 1, 2015·Thrombosis Research·Petra Jilma-StohlawetzBernd Jilma
Jul 3, 2010·Journal of Molecular and Cellular Cardiology·Timothy P McFarlandSteven E Cala
Jul 1, 2009·Journal of Cardiovascular Electrophysiology·Nagesh Chopra, Björn C Knollmann
Nov 29, 2005·Life Sciences·Roberto Roncon-AlbuquerqueAdelino F Leite-Moreira
Mar 23, 2010·Journal of Molecular and Cellular Cardiology·Uwe KirchheferJoachim Neumann
Feb 3, 2015·Journal of Molecular and Cellular Cardiology·Naama H SleimanSteven E Cala
Sep 21, 2016·International Journal of Molecular Sciences·Kevin M LewisChulHee Kang
Feb 5, 2014·Circulation. Arrhythmia and Electrophysiology·Michela FaggioniBjörn C Knollmann
Apr 3, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Ulrich GergsJoachim Neumann
Oct 8, 2013·Journal of Muscle Research and Cell Motility·Katharine M SharpeDeWayne Townsend
Feb 26, 2013·Heart Failure Reviews·Jamille LocatelliMauro C Isoldi
Mar 5, 2013·Molecular and Cellular Biochemistry·Sony JacobSteven E Cala
Mar 19, 2011·Molecular and Cellular Biochemistry·Emiliano J SanchezChulhee Kang
Jul 21, 2017·Journal of Inherited Metabolic Disease·D Marques-da-SilvaT Pulinilkunnil
Dec 20, 2014·The Journal of Biological Chemistry·Andrew R Ednie, Eric S Bennett
May 29, 2018·Current Cardiology Reports·Arne A N BruyneelMark Mercola
Jun 24, 2020·Cell Calcium·Qian Wang, Marek Michalak
Jun 15, 2021·Frontiers in Molecular Biosciences·Patricia FranzkaChristian A Hübner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.